Gastrointestinal Bleeding Study Analysis

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the adjusted risk ratio (RR) for gastrointestinal bleeding associated with the combination of warfarin and acetylsalicylic acid?

2.23 (correct)

1.94

6.48

4.00

Which known risk factor for gastrointestinal bleeding has the highest adjusted risk ratio (RR) listed?

Liver failure (correct)

Heavy alcohol use

Male sex

Smoking

What was the primary characteristic of the population studied in the case–control study?

Patients with chronic illnesses

Patients over 18 years with a first-ever diagnosis of gastrointestinal bleeding (correct)

Adults with a history of gastrointestinal conditions

Children under 18 years of age

What was the adjusted risk ratio (RR) for patients taking warfarin alone?

1.94 Signup and view all the answers

Which factor has the lowest adjusted risk ratio (RR) associated with an increased risk of gastrointestinal bleeding?

Smoking Signup and view all the answers

How many cases of gastrointestinal bleeding were identified in the study?

4028 Signup and view all the answers

Which two drugs were associated with an increased risk of gastrointestinal bleeding?

Acetylsalicylic acid and clopidogrel Signup and view all the answers

What is the adjusted risk ratio (RR) for gastrointestinal bleeding from heavy alcohol use?

4.00 Signup and view all the answers

What was the duration of data collection for the study?

From January 1, 2000, to December 31, 2005 Signup and view all the answers

What is the effect of combining warfarin and acetylsalicylic acid on the risk of gastrointestinal bleeding, as indicated by the adjusted risk ratio?

6.48 Signup and view all the answers

What criteria were used to match cases and controls in the study?

Physician practice, patient age, and index date Signup and view all the answers

Among the factors listed, which one solely contributes an adjusted RR of 1.47 for gastrointestinal bleeding?

Acetaminophen Signup and view all the answers

What does the combination of clopidogrel with a nonsteroidal anti-inflammatory drug (NSAID) indicate in terms of adjusted risk ratio (RR)?

2.93 Signup and view all the answers

What type of database was used for this study?

A well-validated network database of general practices Signup and view all the answers

Which of the following statements is true regarding the database used in the research?

It captures all important medical events and prescriptions. Signup and view all the answers

What was the adjusted rate ratio for the risk of gastrointestinal bleeding associated with the prescribing of warfarin?

6.48 Signup and view all the answers

What is the risk associated with combining antiplatelets and anticoagulants?

It significantly increases the risk of gastrointestinal bleeding. Signup and view all the answers

What criteria were used to define a case in the study?

Patients with a first-ever entry of gastrointestinal bleeding in their record. Signup and view all the answers

What was the adjusted relative risk (RR) when combining a nonsteroidal anti-inflammatory drug with clopidogrel?

2.93 Signup and view all the answers

What must patients have to be included in the study?

At least 3 years of medical records. Signup and view all the answers

How many controls were selected for every case in the database?

Up to 10 controls. Signup and view all the answers

Which of the following medications was associated with a relative risk of 4.60 when combined with a nonsteroidal anti-inflammatory drug?

Warfarin Signup and view all the answers

What demographic information was used to match controls in the study?

Patient age and index date. Signup and view all the answers

What is the primary interpretation regarding drug combinations in this study?

They pose significant gastrointestinal bleeding risks. Signup and view all the answers

Which agents are known to pose renal risks alongside cardiac risks?

Cyclooxygenase-2 selective inhibitors Signup and view all the answers

Which drug is associated with a higher risk of gastrointestinal bleeding compared to cyclooxygenase-2 selective inhibitors?

Conventional nonsteroidal anti-inflammatory drugs Signup and view all the answers

What should physicians be aware of when prescribing antithrombotic agents?

Potential drug-drug interactions and risk of gastrointestinal bleeding Signup and view all the answers

Which of the following statements about cyclooxygenase-2 selective inhibitors is correct?

Their risks appear comparable to conventional nonsteroidal anti-inflammatory drugs. Signup and view all the answers

What does the forest plot in Figure 1 represent?

Gastrointestinal bleeding risks associated with different drugs. Signup and view all the answers

Which group of patients should be especially monitored for gastrointestinal risks?

Patients taking both ASA and clopidogrel Signup and view all the answers

What is the role of the contributors mentioned in the content?

Conception, design, and data interpretation Signup and view all the answers

Which statement is false regarding the risk assessment of drug interactions?

All anticoagulants carry the same level of gastrointestinal risk. Signup and view all the answers

What was the main finding of the study regarding gastrointestinal bleeding?

Increased risk with drug-drug interactions Signup and view all the answers

How did the estimates of gastrointestinal bleeding in this study compare to those from clinical trials?

They were higher than estimates from clinical trials. Signup and view all the answers

What limitation did the study have concerning data collection?

Dependence on physician records Signup and view all the answers

Where was the study population primarily based?

United Kingdom Signup and view all the answers

Which funding organization supported the study?

Canadian Institutes of Health Research Signup and view all the answers

What distinction is Samy Suissa associated with in this study?

Distinguished Scientist Award recipient Signup and view all the answers

What was noted about the monitoring of patients in the study?

It was less strict than in clinical trials. Signup and view all the answers

Which antithrombotic agent was specifically mentioned in the study?

Acetylsalicylic acid Signup and view all the answers

Study Notes

Study Design and Population

This was a retrospective case-control study using data from the UK General Practice Research Database (2000-2005).
The study included patients over 18 years old with records containing a first-ever diagnosis of gastrointestinal bleeding.
Controls were matched to cases based on physician practice, patient age (within ± 2 years), and index date (date of diagnosis of bleeding).
All eligible patients had at least 3 years of follow-up data in the database.

Key Findings

Known risk factors for gastrointestinal bleeding (e.g. male sex, heavy alcohol use, smoking, acetaminophen use, and liver failure) were associated with increased risk in the study.
Combining acetylsalicylic acid (ASA) with clopidogrel or warfarin was associated with a significantly higher risk of gastrointestinal bleeding than either drug alone.
The combination of ASA with other antithrombotic agents yielded a significant interaction term, indicating an added risk beyond the individual risks of each drug.
Combining nonsteroidal anti-inflammatory drugs (NSAIDS) with clopidogrel or warfarin also resulted in a significantly higher risk of gastrointestinal bleeding compared to each drug alone.

Drug Combinations and Risk

Combining acetylsalicylic acid (ASA) with clopidogrel: adjusted rate ratio (RR) 3.90 (95% confidence interval [CI] 2.78–5.47)
Combining ASA with warfarin: adjusted RR 6.48 (95% CI 4.25–9.87)
Combining NSAIDS with clopidogrel: adjusted RR 2.93 (95% CI 1.74–4.93)
Combining NSAIDS with warfarin: adjusted RR 4.60 (95% CI 2.77–7.64)

Interpretation

These combinations of drugs, particularly those involving antiplatelets and anticoagulants, carry a high risk of gastrointestinal bleeding beyond the risks associated with each drug used individually.
Physicians should be mindful of these risks when prescribing these combinations and carefully assess their patients' therapeutic risk-benefit profiles.
The findings may be even more relevant for cyclooxygenase-2 selective inhibitors due to their known cardiac and renal risks.
Despite lower bleeding risk compared to traditional NSAIDs, the risk of gastrointestinal bleeding associated with cyclooxygenase-2 selective inhibitors may be similar when combined with antithrombotic agents.
The study is population-based, making the inferences relevant to real-world clinical settings.
The study's limitation is that it relies on physician records, which may introduce potential biases.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Description

This quiz explores a retrospective case-control study on gastrointestinal bleeding using the UK General Practice Research Database. Participants over 18 were analyzed based on various known risk factors. The study also investigates the risks associated with drug combinations like ASA and anticoagulants.